ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,820,823 | -10.7% | 103,936 | +1.1% | 0.02% | -7.7% |
| Q2 2023 | $3,160,133 | -14.5% | 102,802 | +0.2% | 0.03% | -21.2% |
| Q1 2023 | $3,696,426 | -5.5% | 102,593 | +3.6% | 0.03% | -13.2% |
| Q4 2022 | $3,912,006 | +1.8% | 98,988 | +3.5% | 0.04% | -5.0% |
| Q3 2022 | $3,842,000 | -5.5% | 95,619 | -1.1% | 0.04% | +2.6% |
| Q2 2022 | $4,064,000 | +9.1% | 96,670 | +1.1% | 0.04% | +30.0% |
| Q1 2022 | $3,726,000 | +0.5% | 95,646 | +2.8% | 0.03% | +7.1% |
| Q4 2021 | $3,706,000 | +106.7% | 93,007 | +87.5% | 0.03% | +86.7% |
| Q3 2021 | $1,793,000 | -11.4% | 49,613 | +0.5% | 0.02% | -6.2% |
| Q2 2021 | $2,024,000 | -7.9% | 49,367 | -2.0% | 0.02% | -15.8% |
| Q1 2021 | $2,197,000 | +34.6% | 50,359 | +54.4% | 0.02% | +26.7% |
| Q4 2020 | $1,632,000 | – | 32,613 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |